Gramicidin
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
Gramicidin
CAS RN®: 1405-97-6; UNII: 5IE62321P4.
1 DEFINITION
Gramicidin is an antibacterial substance produced by the growth of Bacillus brevis Dubos (Fam. Bacillaceae). It may be obtained from Tyrothricin. It has a potency of NLT 900 µg of gramicidin per mg, calculated on the dried basis.
2 IDENTIFICATION
Delete the following:
Spectroscopic Identification Tests, 〈197〉Ultraviolet-Visible Spectroscopy (USP 1-Dec-2023)
Add the following:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (USP 1-Dec-2023)
Add the following:
B. The retention times of the major peaks of the Sample solution correspond to those of the Standard solution, as obtained in the test for Composition. (USP 1-Dec-2023)
3 ASSAY
Change to read:
Antibiotics—Microbial Assays 〈81〉: Determine the median concentration (S3), starting with the concentration suggested in 〈81〉, Table 7, to obtain the optimum concentration–response relationship. (USP 1-Dec-2023)
Acceptance criteria: It has a potency of NLT 900 µg of gramicidin per mg calculated on the dried basis.
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 1.0%, the charred residue being moistened with 2 mL of nitric acid and 5 drops of sulfuric acid Add the following:
Organic Impurities
Mobile phase: Methanol and water (71:29)
Sensitivity solution: 2 µg/mL of USP Gramicidin RS in Mobile phase
Standard solution: 1 mg/mL of USP Gramicidin RS in Mobile phase
Sample solution: 1 mg/mL of Gramicidin in Mobile phase
4.1 Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 282 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Column temperature: 50°
Flow rate: 1.0 mL/min
Injection volume: 20 µL
4.2 System suitability
Samples: Sensitivity solution and Standard solution
[Note—The relative retention times in Table 1 are provided as information that could aid in peak assignment.]
Table 1
Name | Relative Retention Time |
Gramicidin C1a | 0.7 |
Gramicidin C2b | 0.8 |
Gramicidin A1c | 1.0 |
Gramicidin A2d | 1.2 |
Gramicidin B1e | 1.9 |
a N-Formyl-l-valylglycyl-l-alanyl-d-leucyl-l-alanyl-d-valyl-l-valyl-d-valyl-l-tryptophyl-d-leucyl-l-tyrosyl-d-leucyl-l-tryptophyl-d-leucyl-N-(2- hydroxyethyl)-l-tryptophanamide.
b N-Formyl-l-isoleucylglycyl-l-alanyl-d-leucyl-l-alanyl-d-valyl-l-valyl-d-valyl-l-tryptophyl-d-leucyl-l-tyrosyl-d-leucyl-l-tryptophyl-d-leucyl-N-(2- hydroxyethyl)-l-tryptophanamide.
c N-Formyl-l-valylglycyl-l-alanyl-d-leucyl-l-alanyl-d-valyl-l-valyl-d-valyl-l-tryptophyl-d-leucyl-l-tryptophyl-d-leucyl-l-tryptophyl-d-leucyl-N-(2- hydroxyethyl)-l-tryptophanamide.
d N-Formyl-l-isoleucylglycyl-l-alanyl-d-leucyl-l-alanyl-d-valyl-l-valyl-d-valyl-l-tryptophyl-d-leucyl-l-tryptophyl-d-leucyl-l-tryptophyl-d-leucyl-N- (2-hydroxyethyl)-l-tryptophanamide.
e N-Formyl-l-valylglycyl-l-alanyl-d-leucyl-l-alanyl-d-valyl-l-valyl-d-valyl-l-tryptophyl-d-leucyl-l-phenylalanyl-d-leucyl-l-tryptophyl-d-leucyl-N-(2- hydroxyethyl)-l-tryptophanamide.
Suitability requirements
Resolution: NLT 1.5 between gramicidin A1 and gramicidin A2, Standard solution
Signal-to-noise ratio: NLT 10 for the gramicidin A1 peak, Sensitivity solution
4.3 Analysis
Sample: Sample solution
Calculate the percentage of each impurity peak (the peak other than gramicidins A1, A2, B1, C1, and C2):
Result = (rU /rT ) × 100
rU = peak response of the individual impurity
rT = total response of all the peaks
Acceptance criteria: Disregard any impurity with a peak area less than that of gramicidin A1 in the Sensitivity solution. NMT 1 impurity exceeds 1.0%.
Any individual impurity: NMT 2.0 (USP 1-Dec-2023)
5 SPECIFIC TESTS
Melting Range or Temperature 〈741〉, Procedures, Procedure for Class Ia: NLT 229°, determined after drying
Crystallinity 〈695〉: Meets the requirements
Loss on Drying 〈731〉
Sample: About 100 mg
Analysis: Dry the Sample in a capillary-stoppered bottle in vacuum at 60° for 3 h.
Acceptance criteria: NMT 3.0%
Add the following:
Composition
Mobile phase, Sensitivity solution, Standard solution, Sample solution, Chromatographic system, and System suitability: Proceed as directed in the Organic Impurities.
Analysis
Sample: Sample solution
Calculate the percentage of each of the components (gramicidins A1, A2, B1, C1, and C2):
Result = (rU /rT) × 100
rU = peak response of the individual component
rT = total response of all the peaks
Acceptance criteria: See Table 2.
Table 2
Name | Acceptance Criteria |
Ratio of gramicidin A1 to the sum of gramicidins A1, A2, B1, C1, and C2 | NLT 0.60 |
Sum of gramicidins A1, A2, B1, C1, and C2 | NLT 95.0% (USP 1-Dec-2023) |
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight containers.
USP Reference Standards 〈11〉
USP Gramicidin RS.

